The value of interleukin-6 (IL-6) within 6 hours after birth in the prompt diagnosis of early-onset neonatal sepsis

Chunmei Liu, Chengzhi Fang, Qi He, Lili Xie, Chunmei Liu, Chengzhi Fang, Qi He, Lili Xie

Abstract

Background: To investigate the value of interleukin-6 (IL-6) for neonates within 6 hours after birth in the prompt diagnosis of early-onset neonatal sepsis (EONS).

Methods: The clinical and laboratory data of 129 neonates in the neonatal intensive care unit (NICU) of our center from March 31, 2017, to February 29, 2020, were retrospectively analyzed. These patients were divided into two groups on their disease conditions: the EONS group (n=66) and the healthy control group (n=63). All enrolled patients were born in our hospital's Obstetrics Department and were admitted to the NICU within 2 hours after birth. The first session of the blood test was conducted within 4-6 hours after birth for the measurements of IL-6, C-reactive protein (CRP1), serum amyloid A1 (SAA1), and serum immunoglobulin M (IgM). The second session of the blood test was performed 12-24 hours after birth for procalcitonin (PCT), CRP2, and SAA2. All the tests were completed in our clinical laboratory. The non-parametric test (Mann-Whitney U test) was used to compare all parameters between these two groups. The receiver operating characteristic (ROC) curves were drawn to compare the diagnostic sensitivities and specificities. The pairwise comparisons of the ROC curves were on the MedCalc18.2.1 software. A P value of <0.05 was considered statistically significant.

Results: Gender, birth weight, and gestational age were matched between the EONS group and the control group (all P>0.05). The differences of IL-6, CRP2, PCT, and SAA2 were statistically significant between these two groups (all P<0.05), while there was no significant difference in CRP1, SAA1, and IgM (all P>0.05). The area under the ROC curve (AUC) is 1 (95% CI: 0.918-1.000), 1 (95% CI: 0.918-1.000), 1 (95% CI: 0.918-1.000), and 0.977 (95% CI: 0.878-0.999), respectively, for IL-6, CRP2, PCT, and SAA2. Pairwise comparisons among four biomarkers showed the diagnostic specificity and sensitivity of IL-6 were not significantly different from those of CRP2, PCT, and SAA2 (all P>0.05).

Conclusions: IL-6 is a quick and independent diagnostic biomarker for EONS, and its sensitivity and specificity are inferior to the conventional inflammation markers, including CRP, PCT, and SAA.

Keywords: Interleukin-6 (IL-6); early diagnosis; early-onset neonatal sepsis (EONS).

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tp-20-239). The authors have no conflicts of interest to declare.

2020 Translational Pediatrics. All rights reserved.

Figures

Figure 1
Figure 1
ROC curves for the diagnostic values of IL-6, PCT, CRP2, and SAA2. ROC, receiver operating characteristic.

References

    1. Adams M, Bassler D. Practice variations and rates of late onset sepsis and necrotizing enterocolitis in very preterm born infants, a review. Transl Pediatr 2019;8:212-26. 10.21037/tp.2019.07.02
    1. Yuan H, Huang J, Lv B, et al. Diagnosis value of the serum amyloid A test in neonatal sepsis: a meta-analysis. Biomed Res Int 2013;2013:520294.
    1. Janeway CA, Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002;20:197-216.
    1. Chiesa C, Pacifico L, Natale F, et al. Fetal and early neonatal interleukin-6 response. Cytokine 2015;76:1-12.
    1. Pavcnik-Arnol M, Hojker S, Derganc M. Lipopolysaccharide-binding protein in critically ill neonates and children with suspected infection: comparison with procalcitonin, interleukin-6, and C-reactive protein. Intensive Care Med 2004;30:1454-60. 10.1007/s00134-004-2307-4
    1. Kishimoto T. The biology of interleukin-6. Blood 1989;74:1-10. 10.1182/blood.V74.1.1.1
    1. Park H, Park KH, Kim YM, et al. Plasma inflammatory and immune proteins as predictors of intra-amniotic infection and spontaneous preterm delivery in women with preterm labor: a retrospective study. BMC Pregnancy Childbirth 2018;18:146. 10.1186/s12884-018-1780-7
    1. Bhandari A, Bhandari V. Biomarkers in bronchopulmonary dysplasia. Paediatr Respir Rev 2013;14:173-9. 10.1016/j.prrv.2013.02.008
    1. Maheshwari A, Schelonka RL, Dimmitt RA, et al. Cytokines associated with necrotizing enterocolitis in extremely-low-birth-weight infants. Pediatr Res 2014;76:100-8. 10.1038/pr.2014.48
    1. Stocker M, van Herk W, El Helou S, et al. Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (NeoPIns). Lancet 2017;390:871-81. 10.1016/S0140-6736(17)31444-7
    1. Weiss SL, Fitzgerald JC, Balamuth F, et al. Delayed antimicrobial therapy increases mortality and organ dysfunction duration in pediatric sepsis. Crit Care Med 2014;42:2409-17. 10.1097/CCM.0000000000000509
    1. Tanimura K, Yamada H. Potential Biomarkers for Predicting Congenital Cytomegalovirus Infection. Int J Mol Sci 2018;19:3760. 10.3390/ijms19123760
    1. Subspecialty Group of Neonatology , the Society of Pediatric, Chinese Medical Association; Professional Committee of Infectious Diseases, Neonatology Society, Chinese Medical Doctor Association. Zhonghua Er Ke Za Zhi 2019;57:252-7.
    1. Burchfield DJ. RE: Management of Neonates Born at ≤34 6/7 Weeks' Gestation With Suspected or Proven Early-Onset Bacterial Sepsis. Pediatrics 2019;143:e20190533A. 10.1542/peds.2019-0533A
    1. Simonsen KA, Anderson-Berry AL, Delair SF, et al. Early-onset neonatal sepsis. Clin Microbiol Rev 2014;27:21-47. 10.1128/CMR.00031-13
    1. Sack GH, Jr. Serum Amyloid A (SAA) Proteins. Subcell Biochem. 2020;94:421-36. 10.1007/978-3-030-41769-7_17
    1. Chauhan N, Tiwari S, Jain U. Potential biomarkers for effective screening of neonatal sepsis infections: An overview. Microb Pathog 2017;107:234-42. 10.1016/j.micpath.2017.03.042
    1. van Rossum AM, Wulkan RW, Oudesluys-Murphy AM. Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis 2004;4:620-30. 10.1016/S1473-3099(04)01146-6
    1. Liu C, Fang C, Xie L. Diagnostic utility of procalcitonin as a biomarker for late-onset neonatal sepsis. Transl Pediatr 2020;9:237-42. 10.21037/tp-20-127
    1. Zhao FX, Liu GH, Zhang J. Value of IL-6 and IL-8 in the diagnosis of neonatal sepsis. Zhongguo Dang Dai Er Ke Za Zhi 2015;17:1311-5.
    1. Boskabadi H, Zakerihamidi M. Evaluate the diagnosis of neonatal sepsis by measuring interleukins: A systematic review. Pediatr Neonatol 2018;59:329-38. 10.1016/j.pedneo.2017.10.004
    1. Torii Y, Yoshida S, Yanase Y, et al. Serological screening of immunoglobulin M and immunoglobulin G during pregnancy for predicting congenital cytomegalovirus infection. BMC Pregnancy Childbirth 2019;19:205. 10.1186/s12884-019-2360-1

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir